What does CUSIP 02043Q107 represent in this 13F holders report?

CUSIP 02043Q107 is the security identifier for ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock in Q4 2022?

477 institutional investors reported ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock for Q4 2022. Use the holders table for investor-level position and value details.

ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)

CUSIP: 02043Q107

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Stock
Total 13F shares: 119,654,959
Total 13F value: $28,425,215,078
Share change: -13,407,340
Put/Call ratio: 53%
SEC-reported price per share: $237.65
Number of holders: 477
Value change: -$3,086,850,614
Number of buys: 241
Number of sells: 224
Shares outstanding: 133,131,695

Security key

02043Q107

Report period

Q4 2022

Institutions

477

Top holders

ALNY full security history Ownership snapshot Full 13F holder table ALNYLAM PHARMACEUTICALS, INC. SEC filings ALNYLAM PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Nuveen Asset Management, LLC

Disclosed value leader

Nuveen Asset Management, LLC

Comparable rows

15/15

Latest evidence

30 Sep 2022

13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

Nuveen Asset Management, LLC leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nuveen Asset Management, LLC's linked filing trail.

Comparable ownership Top 5

Nuveen Asset Management, LLC 12%

Capital World Investors 10%

FMR LLC 9.7%

VANGUARD GROUP INC 8.3%

BAILLIE GIFFORD & CO 7.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Nuveen Asset Management, LLC	13F Company 13F	12%	$3,321,309,000 16,593,268 shares	—	30 Sep 2022
Capital World Investors	13F Company 13F	10%	$2,792,252,000 13,949,647 shares	—	30 Sep 2022
FMR LLC	13F Company 13F	9.7%	$2,592,024,000 12,949,757 shares	—	30 Sep 2022
VANGUARD GROUP INC	13F Company 13F	8.3%	$2,212,429,000 11,053,308 shares	—	30 Sep 2022
BAILLIE GIFFORD & CO	13F Company 13F	7.1%	$1,904,474,000 9,514,758 shares	—	30 Sep 2022
BlackRock Finance, Inc.	13F Company 13F	5.8%	$1,534,961,000 7,668,678 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

477

119,654,959

Rows available

477

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

479

Q4 2022 holders

477

Holder diff

-2

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 value	Q4 2022 value	Value change	Value Chg %